Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
acetone-serum

Spinocerebellar Ataxia Type 17 (SCA17)

Spinocerebellar Ataxia Type 17 (SCA17) is a rare genetic neurodegenerative disorder characterized by progressively worsening coordination and balance (ataxia). SCA17 is caused by a specific gene mutation and is part of a larger group of genetic ataxia disorders. Genetic testing can confirm the diagnosis and provide valuable information for disease management and family planning.


  • Test NameSpinocerebellar Ataxia Type 17 (SCA17)
  • Sample TypeBlood
  • Preparations RequiredNo specific preparations, dietary restrictions, or fasting is necessary before providing a blood sample for this test.
  • Report Time9 Days

This guide will answer some of the most commonly asked questions about SCA17 and its implications for you and your family.

Home Sample Collection Process

1
Book your convenient slot
Book your convenient slot
2
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
3
Reporting of the sample at lab
Reporting of the sample at lab
4
Download Reports
Download Reports
Frequently Asked Questions

Getting a test for SCA17 is crucial if you have a family history of ataxia or are experiencing symptoms like impaired coordination, balance problems, and cognitive decline. Early diagnosis can lead to better management of symptoms and provide information about the risk to other family members.

No, fasting is not required for the SCA17 genetic test.

No specific preparation is needed for the SCA17 genetic test.

If you exhibit symptoms of ataxia, such as impaired coordination, balance issues, cognitive decline, psychiatric symptoms, and if there's a family history of such symptoms, you should consider getting this test.

The SCA17 genetic test identifies the specific mutation associated with SCA17. It can aid in confirming the diagnosis, managing the condition, and understanding the risk to other family members.

The SCA17 genetic test is typically a one-time procedure. However, regular check-ups are necessary to monitor disease progression and manage symptoms.

In a genetic test, a normal result indicates the absence of the specific gene mutation associated with SCA17.

There are no specific precautions required for this test. Given the genetic implications of the results, genetic counseling might be beneficial before and after testing.

The SCA17 genetic test is not influenced by external factors. However, potential laboratory errors or issues with the blood sample could potentially affect the results.

If your SCA17 test results are positive, you should consult a neurologist or a genetic counselor.

A positive test result confirms the diagnosis of SCA17. A management plan, which might include physical therapy, medication for psychiatric symptoms or other interventions, can be devised. Genetic counseling can also provide support and information.

No, the SCA17 genetic test requires a blood sample, which should be collected by a healthcare professional and processed in a specialized lab.

The SCA17 test involves a standard blood draw, so risks are minimal. However, some people might experience slight pain, bruising, or infection at the injection site.

A negative test result means you do not have the specific gene mutation associated with SCA17. However, it does not rule out other types of ataxia or similar disorders.

The SCA17 genetic test is highly reliable and accurate when conducted in a credible lab. However, it's always important to discuss your results with a healthcare professional or genetic counselor.

Since SCA17 is a genetic disorder, it cannot be prevented if the mutation is present. However, symptoms can be managed, and genetic counseling can provide valuable insights for family planning.

SCA17 is inherited in an autosomal dominant manner, which means an affected person has a 50% chance of passing the mutation to each child.

The symptoms of SCA17 typically include ataxia (poor coordination and balance), cognitive decline, psychiatric symptoms such as depression and irritability, and in some cases, movement disorders like chorea and dystonia.

Yes, physical therapy can be helpful in managing ataxia and improving coordination and balance. Speech and occupational therapy might also be beneficial.

While there's no cure or specific drug for SCA17, medications can help manage symptoms like movement disorders and psychiatric symptoms. Regular medical check-ups are vital to adjust the treatment plan as needed.

SCA17 can make daily tasks challenging due to balance and coordination issues, and cognitive decline. However, with physical therapy and necessary adaptations, individuals with SCA17 can manage daily activities.

SCA17 is a rare form of spinocerebellar ataxia. Its prevalence varies globally, with certain regions having more cases due to specific genetic backgrounds.

SCA17 typically presents in adulthood, but in rare cases, symptoms can appear in childhood. A genetic test can confirm the diagnosis.

Support groups, both online and in-person, can provide emotional support and practical advice. Genetic counseling can also be beneficial for affected individuals and their families.

Current research is exploring various approaches to treat SCA17 more effectively, with some looking at ways to stop or reverse the effects of the genetic mutation.

SCA17 is a lifelong journey that requires careful management, but with the right support and treatment, individuals can lead fulfilling lives. Staying informed and connected with healthcare providers is key to managing SCA17 effectively. Remember that while SCA17 is a part of your life, it doesn't define it. Keep embracing your life with strength, resilience, and optimism.

Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet